Antimicrobial Susceptibility Patterns of Common Complicated Urinary Tract Infection Pathogens in US Hospitals, 2013-2018 Posted on October 4, 2019 at 3:34 pm.Written by Spero Therapeutics View Presentation Post navigation Characterization of Tebipenem (SPR859) Pharmacokinetics- Pharmacodynamics (PK-PD) for Efficacy Against Enterobacteriaceae in a One-Compartment In Vitro Infection ModelEpidemiology, Empiric Treatment, and Outcomes Among Hospitalized Patients with Complicated Urinary Tract Infections in the US, 2013-2018
